Novel immunotherapy saves a dog from rare cancer
A novel immunotherapy treatment has saved family dog Griffin from a rare type of cancer, thanks to collaborative research at The University of Queensland.
A novel immunotherapy treatment has saved family dog Griffin from a rare type of cancer, thanks to collaborative research at The University of Queensland.
Veterinary medicine
Jan 3, 2020
0
15
A protein which is intimately involved in cancer-promoting cell signaling also keeps a key component of the signaling pathway tied down and inactive, a team led by scientists from The University of Texas MD Anderson Cancer ...
Cell & Microbiology
Apr 19, 2013
0
0
Cancer that has spread to the central nervous system is notoriously difficult to treat. Now, UCLA researchers have developed a drug delivery system that breaks through the blood-brain barrier in order to reach and treat cancer ...
Bio & Medicine
Aug 14, 2019
0
107
Historically, fly and human Polycomb proteins were considered textbook exemplars of transcriptional repressors, or proteins that silence the process by which DNA gives rise to new proteins. Now, work by a team of researchers ...
Cell & Microbiology
Apr 30, 2012
0
0
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.
Cell & Microbiology
Aug 5, 2009
0
0
Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin's lymphoma, chronic ...
Biotechnology
Mar 2, 2011
0
0
A study mapping genes associated with two cancers common in golden retrievers could lead to better prevention and treatment of the disease in dogs as well as similar cancers in people.
Biotechnology
Jan 5, 2016
0
289
(AP) -- Microsoft Corp. co-founder and billionaire investor Paul Allen has been diagnosed with non-Hodgkin's lymphoma and is undergoing chemotherapy.
Other
Nov 17, 2009
0
0
Chimeric antigen receptors (CARs) are synthesized membrane proteins that enable lymphocytes to recognize and respond to the specific antigens of target cells. Despite the impressive efficacy of CAR-T cell therapy in treating ...
Bio & Medicine
Mar 15, 2024
0
7
The Thundercats have nothing on this team of feline heroes.
Plants & Animals
Mar 7, 2019
0
5